| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |